Hospital
Steward Melbourne Hospital, INC.
Steward Melbourne Hospital, INC. was paid $3.35M by Medicaid between Jan 2018 and Nov 2024, across 120 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.
33Billing provider infoSTEWARD MELBOURNE HOSPITAL, INC.
MELBOURNE, FL 32935
MELBOURNE, FL 32935
33aNPI1801320718assigned 04/18/2017
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.35M
24GClaims153,583
24DCodes billed120
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#101 of 163
Median peer was paid$4.77M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DOYLE, JOHN controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,276 | $56K | |
| 2019 | 26,543 | $450K | |
| 2020 | 26,978 | $434K | |
| 2021 | 33,912 | $697K | |
| 2022 | 35,130 | $935K | |
| 2023 | 17,596 | $581K | |
| 2024incomplete | 5,148 | $196K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 10,110 | 8,774 | $728K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 10,334 | 8,674 | $634K |
| 36415 | Collection of venous blood by venipuncture | 10.0% | 10,198 | 7,030 | $334K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.8% | 6,173 | 4,826 | $329K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7.0% | 1,124 | 959 | $235K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.3% | 3,467 | 2,708 | $145K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.3% | 1,431 | 1,128 | $145K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.1% | 493 | 409 | $105K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.6% | 1,793 | 413 | $88K |
| 80053 | Comprehensive metabolic panel | 2.0% | 8,674 | 6,613 | $69K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.7% | 487 | 212 | $58K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.0% | 464 | 401 | $34K |
108 more codes
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,203 | $33K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 431 | $30K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,751 | $26K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 299 | $26K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,862 | $24K |
| 87081 | <1% | 1,286 | $22K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,910 | $21K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 214 | $19K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,945 | $17K |
| 81025 | <1% | 1,838 | $15K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,378 | $14K |
| 82947 | <1% | 1,079 | $14K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 439 | $13K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 511 | $12K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 75 | $12K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,237 | $10K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,975 | $9K |
| 81001 | <1% | 3,229 | $9K | |
| 73630 | <1% | 367 | $9K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 731 | $8K |
| 81003 | <1% | 2,061 | $8K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 32 | $8K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,210 | $6K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 408 | $6K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,313 | $5K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 531 | $5K |
| 84484 | <1% | 3,458 | $5K | |
| 82962 | <1% | 915 | $5K | |
| 00811 | <1% | 85 | $4K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 134 | $4K |
| 00731 | <1% | 140 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,333 | $3K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 90 | $3K |
| J2704 | Injection, propofol, 10 mg | <1% | 3,215 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 56 | $2K |
| 73562 | <1% | 111 | $2K | |
| 73130 | <1% | 72 | $2K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 15 | $2K |
| 73110 | <1% | 47 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,401 | $2K |
| 71250 | <1% | 36 | $2K | |
| 85610 | <1% | 1,645 | $2K | |
| G0378 | Hospital observation service, per hour | <1% | 358 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 19 | $1K |
| 97161 | <1% | 91 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,332 | $1K |
| 86900 | <1% | 128 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,997 | $1K |
| 76830 | Ultrasound, transvaginal | <1% | 14 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,772 | $970.70 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,658 | $950.14 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 32 | $876.68 |
| 83690 | <1% | 2,493 | $838.78 | |
| 85379 | <1% | 425 | $807.14 | |
| 86901 | <1% | 127 | $794.10 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 285 | $745.37 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,660 | $731.78 |
| 73610 | <1% | 89 | $708.64 | |
| 83605 | <1% | 543 | $673.35 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 43 | $652.72 |
| 84600 | <1% | 75 | $467.77 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 668 | $453.55 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 12 | $429.64 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 737 | $402.20 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,478 | $354.33 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 17 | $300.61 |
| 84703 | <1% | 1,053 | $289.47 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,441 | $276.36 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 570 | $255.17 |
| 83880 | <1% | 863 | $246.34 | |
| 85730 | <1% | 506 | $238.43 | |
| 80050 | General health panel | <1% | 27 | $236.01 |
| 88342 | <1% | 412 | $212.97 | |
| 87040 | <1% | 536 | $122.90 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 914 | $119.49 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 353 | $85.65 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 316 | $77.92 |
| 85027 | <1% | 62 | $60.79 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 286 | $60.60 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 625 | $42.03 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 308 | $40.00 |
| 87428 | <1% | 48 | $23.30 | |
| 87186 | <1% | 108 | $20.98 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 106 | $19.73 |
| 84702 | <1% | 154 | $13.92 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 39 | $11.52 |
| 86850 | <1% | 35 | $8.22 | |
| 83735 | <1% | 337 | $6.10 | |
| 82150 | <1% | 184 | $5.94 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 66 | $1.56 |
| 94760 | 0% | 134 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 271 | $0.00 |
| 87807 | 0% | 111 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 73 | $0.00 |
| 82550 | 0% | 17 | $0.00 | |
| 96376 | 0% | 34 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 59 | $0.00 |
| 87088 | 0% | 60 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 29 | $0.00 |
| 85651 | 0% | 18 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 28 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 361 | $0.00 |
| 80061 | Lipid panel | 0% | 89 | $0.00 |
| 90715 | 0% | 13 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 25 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 13 | $0.00 |
| 88313 | 0% | 14 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOYLE, JOHN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Steward ST. Annes Hospital Corporation | Fall River, MA | $82.71M |
| Steward Trumbull Memorial Hospital, INC. | Warren, OH | $16.49M |
| Steward Sharon Regional Health System, INC. | Sharon, PA | $6.76M |
| Steward Rockledge Hospital, INC. | Rockledge, FL | $6.16M |
| Southwest General Hospital LP | San Antonio, TX | $5.84M |
| Steward Sharon Regional Health System, INC. | Sharon, PA | $5.84M |
| SHC Youngstown Ohio Laboratory Services Company LLC | Poland, OH | $3.41M |
| Steward Hillside Rehabilitation Hospital, INC. | Warren, OH | $2.74M |
| Steward Sebastian River Medical Center, INC. | Sebastian, FL | $2.16M |
| Steward Northside Medical Center, INC. | Youngstown, OH | $1.58M |
| Steward Rockledge Hospital, INC. | Rockledge, FL | $974K |
| Newberry County EMS | Newberry, SC | $758K |
| Steward Sharon Regional Health System, INC. | Mercer, PA | $181K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.